Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine (Q34101436)

31 July 2017

1 reference

title

Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine (English)

1 reference

31 July 2017

1 reference

Baumann MH

1

1 reference

31 July 2017

Pablo J

2

1 reference

31 July 2017

Ali SF

3

1 reference

31 July 2017

Rothman RB

4

1 reference

31 July 2017

Mash DC

5

1 reference

31 July 2017

publication date

1 January 2001

1 reference

The alkaloids. Chemistry and biology

31 July 2017

published in

1 reference

31 July 2017

volume

56

1 reference

31 July 2017

page(s)

79-113

1 reference

Data accrue on "visionary" agent to interrupt addiction.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects and aftereffects of ibogaine on morphine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Inhibitory effects of ibogaine on cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

A preliminary investigation of ibogaine: case reports and recommendations for further study

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Treatment of acute opioid withdrawal with ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Medication development of ibogaine as a pharmacotherapy for drug dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Mechanisms of Antiaddictive Actions of Ibogainea

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine possesses a selective affinity for σ2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine antagonizes cocaine-induced locomotor stimulation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine-like effects of noribogaine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Modulation of morphine-induced antinociception by ibogaine and noribogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Enhancement of morphine antinociception by ibogaine and noribogaine in morphine-tolerant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The dopamine hypothesis of reward: past and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neural substrates of drug craving and relapse in drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The role of the striatopallidal and extended amygdala systems in drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neurotransmitter transporters: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Comparative neurobiological effects of ibogaine and MK-801 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Neuropharmacological characterization of local ibogaine effects on dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Time-dependent interactions between iboga agents and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The spectrum of behaviors influenced by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Fluoxetine-induced attenuation of amphetamine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Fluoxetine reduces intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

An animal behavior model for studying central serotonergic synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Endogenous opioids: overview and current issues

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Anatomy of CNS opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The neurobiology of opiate reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

High affinity ibogaine binding to a mu opioid agonist site

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The role of stress in drug self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Influence of housing conditions on the acquisition of intravenous heroin and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Social stress increases the acquisition of cocaine self-administration in male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Role of corticosterone in intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Rats orally self-administer corticosterone.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Forebrain pathways mediating stress-induced hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Dopamine: a prolactin-inhibiting hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Endocrine actions of opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Psycotherapeutic Possibilities of New Fantasy-Enhancing Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine induces glial activation in parasagittal zones of the cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Acute and chronic administration of ibogaine to the rat results in astrogliosis that is not confined to the cerebellar vermis

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Ibogaine neurotoxicity: a re-evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

A dose-response study of ibogaine-induced neuropathology in the rat cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The integration of pharmacological therapy for comorbid psychiatric and addictive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Depression and stimulant dependence: neurobiology and pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

The role of serotonin in craving: from basic research to human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

A risk-benefit assessment of tramadol in the management of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Kappa opioid inhibition of morphine and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

Cocaine, dopamine and the endogenous opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956009-5

7 January 2021

10.1016/S0099-9598(01)56009-5

Identifiers

DOI

1 reference

31 July 2017

1 reference